United Kingdom

People: Sonoma Pharmaceuticals Inc (SNOA.OQ)

SNOA.OQ on NASDAQ Stock Exchange Capital Market

23 Oct 2018
Change (% chg)

$-0.06 (-4.20%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Miller, Robert 

Mr. Robert Miller is Chief Financial Officer, Secretary of the Company He was a consultant to us from March 2003 to May 2004. Mr. Miller has served as a director of Scanis, Inc. since 1998 and served as the acting Chief Financial Officer of Scanis from 1998 to June 2006. He was a Chief Financial Officer consultant to Evit Labs from June 2003 to December 2004, Wildlife International Network from October 2002 to December 2005, Endoscopic Technologies from November 2002 to March 2004, Biolog from January 2000 to December 2002 and Webware from August 2000 to August 2002. Prior to this, Mr. Miller was the Chief Financial Officer for GAF Corporation, Penwest Ltd. and Bugle Boy, and the Treasurer of Mead Corporation.

Basic Compensation

Total Annual Compensation, USD 250,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 75,721
Fiscal Year Total, USD 325,721

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --